Cite
HARVARD Citation
Mitchell, A. et al. (2023). Cost Savings and Increased Access With Ultra-Low-Dose Immunotherapy. Journal of clinical oncology. 41 (2), pp. 170-172. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mitchell, A. et al. (2023). Cost Savings and Increased Access With Ultra-Low-Dose Immunotherapy. Journal of clinical oncology. 41 (2), pp. 170-172. [Online].